Literature DB >> 15469510

Peptide-mediated macrolide resistance reveals possible specific interactions in the nascent peptide exit tunnel.

Vladimir Vimberg1, Liqun Xiong, Marne Bailey, Tanel Tenson, Alexander Mankin.   

Abstract

Expression of specific short peptides can render cells resistant to macrolide antibiotics. Peptides conferring resistance to structurally different macrolides including oleandomycin, azithromycin, azaerythromycin, josamycin and a ketolide cethromycin were selected from a random pentapeptide expression library. Analysis of the entire collection of the resistance peptides allowed their classification into five distinct groups according to their sequence similarity and the type of resistance they confer. A strong correlation was observed between the structures of macrolide antibiotics and sequences of the peptides conferring resistance. Such a correlation indicates that sequence-specific interactions between the nascent peptide and the macrolide antibiotic and/or the ribosome can occur in the ribosomal exit tunnel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469510     DOI: 10.1111/j.1365-2958.2004.04290.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  10 in total

Review 1.  Target protection as a key antibiotic resistance mechanism.

Authors:  Daniel N Wilson; Vasili Hauryliuk; Gemma C Atkinson; Alex J O'Neill
Journal:  Nat Rev Microbiol       Date:  2020-06-25       Impact factor: 60.633

Review 2.  How Macrolide Antibiotics Work.

Authors:  Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Trends Biochem Sci       Date:  2018-07-24       Impact factor: 13.807

Review 3.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

4.  A method for selecting cis-acting regulatory sequences that respond to small molecule effectors.

Authors:  Ular Allas; Tanel Tenson
Journal:  BMC Mol Biol       Date:  2010-08-10       Impact factor: 2.946

5.  Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition.

Authors:  Triinu Siibak; Lauri Peil; Liqun Xiong; Alexander Mankin; Jaanus Remme; Tanel Tenson
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

6.  Induction of erm(C) expression by noninducing antibiotics.

Authors:  Marne Bailey; Tobin Chettiath; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

7.  Selective desulfurization significantly expands sequence variety of 3'-peptidyl-tRNA mimics obtained by native chemical ligation.

Authors:  Anna-Skrollan Geiermann; Ronald Micura
Journal:  Chembiochem       Date:  2012-07-11       Impact factor: 3.164

8.  Cj1199 Affect the Development of Erythromycin Resistance in Campylobacter jejuni through Regulation of Leucine Biosynthesis.

Authors:  Haihong Hao; Fei Li; Jing Han; Steven L Foley; Menghong Dai; Xu Wang; Yulian Wang; Lingli Huang; Yawei Sun; Zhenli Liu; Zonghui Yuan
Journal:  Front Microbiol       Date:  2017-01-17       Impact factor: 5.640

9.  Co-produced natural ketolides methymycin and pikromycin inhibit bacterial growth by preventing synthesis of a limited number of proteins.

Authors:  Mashal M Almutairi; Maxim S Svetlov; Douglas A Hansen; Nelli F Khabibullina; Dorota Klepacki; Han-Young Kang; David H Sherman; Nora Vázquez-Laslop; Yury S Polikanov; Alexander S Mankin
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

Review 10.  Ribosomal Antibiotics: Contemporary Challenges.

Authors:  Tamar Auerbach-Nevo; David Baram; Anat Bashan; Matthew Belousoff; Elinor Breiner; Chen Davidovich; Giuseppe Cimicata; Zohar Eyal; Yehuda Halfon; Miri Krupkin; Donna Matzov; Markus Metz; Mruwat Rufayda; Moshe Peretz; Ophir Pick; Erez Pyetan; Haim Rozenberg; Moran Shalev-Benami; Itai Wekselman; Raz Zarivach; Ella Zimmerman; Nofar Assis; Joel Bloch; Hadar Israeli; Rinat Kalaora; Lisha Lim; Ofir Sade-Falk; Tal Shapira; Leena Taha-Salaime; Hua Tang; Ada Yonath
Journal:  Antibiotics (Basel)       Date:  2016-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.